Pleomorphic adenocarcinoma of lacrimal gland
Pleomorphic adenocarcinoma of the lacrimal gland, also known as malignant mixed tumor of the lacrimal gland, has clinical manifestations similar to benign pleomorphic adenoma and histologically has both benign and malignant cell characteristics.
Related Drugs
Thymopentin injection
Indication: 1. For patients with chronic hepatitis B over 18 years old; 2. Various primary or secondary T-cell deficiency diseases (such as congenital immunodeficiency in children); 3. Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.); 4. Various diseases with low cellular immune function (severe immunodeficiency, HIV patients, extreme immunosuppression or congenital thymic insufficiency or athymus, etc.); 5. Adjuvant treatment of tumors; 6. Patients undergoing surgical operations and severe infection operations.
Manufacturer:
Beijing SL Pharmaceutical Co., Ltd.
Thymopentin injection
Indication: 1. For patients with chronic hepatitis B over 18 years old; 2. Various primary or secondary T-cell deficiency diseases (such as congenital immunodeficiency in children); 3. Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.); 4. Various diseases with low cellular immune function (severe immunodeficiency, HIV patients, extreme immunosuppression or congenital thymic insufficiency or athymus, etc.); 5. Adjuvant treatment of tumors; 6. Patients undergoing surgical operations and severe infection operations.
Manufacturer:
Beijing SL Pharmaceutical Co., Ltd.
Thymopentin injection
Indication: 1. For patients with chronic hepatitis B over 18 years old; 2. Various primary or secondary T-cell deficiency diseases (such as congenital immunodeficiency in children); 3. Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.); 4. Various diseases with low cellular immune function (severe immunodeficiency, HIV patients, extreme immunosuppression or congenital thymic insufficiency or athymus, etc.); 5. Adjuvant treatment of tumors; 6. Patients undergoing surgical operations and severe infection operations.
Manufacturer:
Beijing SL Pharmaceutical Co., Ltd.
Thymopentin injection
Indication: 1. For patients with chronic hepatitis B over 18 years old; 2. Various primary or secondary T-cell deficiency diseases (such as congenital immunodeficiency in children); 3. Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.); 4. Various diseases with low cellular immune function (severe immunodeficiency, HIV patients, extreme immunosuppression or congenital thymic insufficiency or athymus, etc.); 5. Adjuvant treatment of tumors; 6. Patients undergoing surgical operations and severe infection operations.
Manufacturer:
Beijing SL Pharmaceutical Co., Ltd.
Thymopentin injection
Indication: 1. For patients with chronic hepatitis B over 18 years old; 2. Various primary or secondary T-cell deficiency diseases (such as congenital immunodeficiency in children); 3. Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.); 4. Various diseases with low cellular immune function (severe immunodeficiency, HIV patients, extreme immunosuppression or congenital thymic insufficiency or athymus, etc.); 5. Adjuvant treatment of tumors; 6. Patients undergoing surgical operations and severe infection operations.
Manufacturer:
Beijing SL Pharmaceutical Co., Ltd.